Skip to main content
OpenTrials

Clinical trial condition

Muscular Dystrophy, Duchenne

Explore clinical trials studying Muscular Dystrophy, Duchenne. Study availability and eligibility vary by location and protocol.

362 public trials 56 recruiting studies
Refine in advanced search Browse all conditions

Muscular Dystrophy, Duchenne trial results

Recruiting

Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT

NCT06564974

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Childrens Hospital Little Rock, Arkansas, United States
  • Loma Linda University Pediatric Subspecialty Clinics Loma Linda, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 33 locations
View Trial Details
Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping

NCT07587242

Conditions
Congenital, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DMD, +22 more
Locations
  • AP-HP Hospital Armand-Trousseau Paris, France
  • Universitaetsklinikum Essen Essen, Germany
  • Universitaetsklinikum Heidelberg Heidelberg, Germany
  • Klinikum der Ludwig-Maximilians-Universitaet Muenchen München, Germany
View all 15 locations
View Trial Details
Recruiting

Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients

NCT07287189

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DMD, Duchenne, +10 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Colorado Children's Aurora, Colorado, United States
  • Lurie Children's Chicago, Illinois, United States
  • UMass Memorial Medical Center Worcester, Massachusetts, United States
View all 21 locations
View Trial Details
Recruiting

A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort

NCT04626674

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Stanford University Palo Alto, California, United States
  • University of California, Davis Sacramento, California, United States
  • Washington University in St. Louis St Louis, Missouri, United States
View Trial Details
Recruiting

The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular Dystrophy

NCT07092540

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy (DMD), Genetic Diseases, Inborn, +8 more
Locations
  • University of Rochester Rochester, New York, United States
  • Stony Brook Medicine Stony Brook, New York, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Nationwide Children's Hospital Columbus, Ohio, United States
View Trial Details
Recruiting

Once Weekly Infant Corticosteroid Trial for DMD

NCT05412394

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • University of Cincinnati Cincinnati, Ohio, United States
  • Nationwide Children's Hospital Columbus, Ohio, United States
  • University of Texas Southwestern Dallas, Texas, United States
View Trial Details
Recruiting

A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping to Evaluate the Safety and Efficacy of ENTR-601-45

NCT07038824

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy (DMD), Genetic Diseases, Inborn, +8 more
Locations
  • University Hospital Gent Ghent, Belgium
  • UZ Leuven Leuven, Belgium
  • Centre Hospitalier Régional de la Citadelle Liège, Belgium
  • IRCCS Ospedale San Raffaele Milan, Italy
View all 15 locations
View Trial Details
Recruiting

A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the Safety and Efficacy of ENTR-601-44

NCT07037862

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy (DMD), Genetic Diseases, Inborn, +8 more
Locations
  • University Hospital Gent Ghent, Belgium
  • UZ Leuven Leuven, Belgium
  • Centre Hospitalier Régional de la Citadelle Liège, Belgium
  • IRCCS Ospedale San Raffaele Milan, Italy
View all 14 locations
View Trial Details

Related conditions